ASX - By Stock
|
PNV |
Re:
Ann: First $A9M sales month and $A10M revenue month
|
|
BuffettWarren
|
197 |
53K |
0 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
197
|
53K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First $A9M sales month and $A10M revenue month
|
|
BuffettWarren
|
197 |
53K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
197
|
53K
|
1
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan Webinar Investor Presentation
|
|
BuffettWarren
|
12 |
2.1K |
9 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
12
|
2.1K
|
9
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan Webinar Investor Presentation
|
|
BuffettWarren
|
12 |
2.1K |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
12
|
2.1K
|
2
|
|
ASX - By Stock
|
DRE |
Re:
Webinar
|
|
BuffettWarren
|
21 |
6.1K |
7 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
21
|
6.1K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
BuffettWarren
|
948 |
357K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
948
|
357K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
BuffettWarren
|
18K |
11M |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
18K
|
11M
|
3
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
BuffettWarren
|
300 |
107K |
2 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
300
|
107K
|
2
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan Signs Know-How Agreement with Mayo Clinic
|
|
BuffettWarren
|
15 |
3.9K |
6 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
15
|
3.9K
|
6
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
BuffettWarren
|
300 |
107K |
1 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
300
|
107K
|
1
|
|
ASX - By Stock
|
RMD Medicine |
Re:
Buy RMD now and get great upside returns in a year or two
|
|
BuffettWarren
|
197 |
111K |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
197
|
111K
|
0
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
BuffettWarren
|
300 |
107K |
5 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
300
|
107K
|
5
|
|
ASX - By Stock
|
RMD Medicine |
Re:
Buy RMD now and get great upside returns in a year or two
|
|
BuffettWarren
|
197 |
111K |
2 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
197
|
111K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First $A9M sales month and $A10M revenue month
|
|
BuffettWarren
|
197 |
53K |
2 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
197
|
53K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
5 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
5
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
4 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
0
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
BuffettWarren
|
182 |
54K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
182
|
54K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
0 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
0
|
|
ASX - By Stock
|
MIN |
Re:
Ann: FY24 Q3 Quarterly Activity Report
|
|
BuffettWarren
|
52 |
23K |
10 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
52
|
23K
|
10
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
BuffettWarren
|
51 |
18K |
4 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
51
|
18K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
BuffettWarren
|
18K |
11M |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
18K
|
11M
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
BuffettWarren
|
51 |
18K |
6 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
51
|
18K
|
6
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Macquarie Australia Conference - Presentation
|
|
BuffettWarren
|
36 |
10K |
7 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
36
|
10K
|
7
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
73
|
27K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
BuffettWarren
|
182 |
54K |
9 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
182
|
54K
|
9
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
BuffettWarren
|
51 |
18K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
51
|
18K
|
3
|
|
ASX - By Stock
|
ILU |
Re:
Ann: 2024 AGM - Chairman's and Managing Director's Addresses
|
|
BuffettWarren
|
5 |
1.6K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
5
|
1.6K
|
0
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
73
|
27K
|
1
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
73
|
27K
|
1
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
73
|
27K
|
2
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
73
|
27K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First $A9M sales month and $A10M revenue month
|
|
BuffettWarren
|
197 |
53K |
14 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
197
|
53K
|
14
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First $A9M sales month and $A10M revenue month
|
|
BuffettWarren
|
197 |
53K |
24 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
197
|
53K
|
24
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
73
|
27K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
3 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
BuffettWarren
|
2.5K |
1.1M |
2 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
BuffettWarren
|
256 |
84K |
4 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
256
|
84K
|
4
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
BuffettWarren
|
217 |
55K |
2 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
217
|
55K
|
2
|
|
Charts
|
EMV |
Re:
Chart
|
|
BuffettWarren
|
2.8K |
1.5M |
1 |
06/05/24 |
06/05/24 |
Charts
|
2.8K
|
1.5M
|
1
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
3 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
73
|
27K
|
3
|
|
ASX - By Stock
|
DRE |
Re:
Ann: High Quality, Mixed Rare Earth Carbonate Produced From Yin
|
|
BuffettWarren
|
167 |
46K |
4 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
167
|
46K
|
4
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
73
|
27K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
BuffettWarren
|
2.8K |
680K |
5 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
2.8K
|
680K
|
5
|
|
ASX - By Stock
|
WBC |
Re:
WBC Q1 Expectations
|
|
BuffettWarren
|
20 |
10K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
20
|
10K
|
1
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Dividend/Distribution - WBC
|
|
BuffettWarren
|
73 |
27K |
5 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
73
|
27K
|
5
|
|
ASX - By Stock
|
ARU |
Re:
Arafura Rare Earths Ltd
|
|
BuffettWarren
|
658 |
307K |
8 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
658
|
307K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
BuffettWarren
|
182 |
54K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
182
|
54K
|
3
|
|